Pancreatitis Relapsing: Clinical Trials

3 trials for Pancreatitis Relapsing, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 terminated, 1 unknown. 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1
Phase 41Not yet recruiting 1

Follow Pancreatitis Relapsing: new trials by email Literature Review of Pancreatitis Relapsing trials Research Report on Pancreatitis Relapsing

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis
Semaglutide, Placebo (Normal Saline) - Hypertriglyceridemia Induced Acute Pancreatitis, Recurrent Acute Pancreatitis
Phase 4Not yet recruitingPeking Union Medical College Hospital3962026-09-012026-06-01
Machine learnINg for the rElapse Risk eValuation in Acute Biliary Pancreatitis.
MINERVA Machine Learning model - Acute Pancreatitis, Pancreatitis Due to Gallstones
UnknownUniversity of Cagliari4302024-01-012023-11-09
Simvastatin in the Prevention of Recurrent Pancreatitis
Simvastatin 40mg, Placebo - Pancreatitis Relapsing
Phase 3TerminatedEnrique de-Madaria832017-09-292025-03-20

Narrower conditions

Pancreatitis (3)  ·  Pancreatitis, Chronic (3)  ·  Hypertriglyceridemia (1)  ·  Recurrence (1)

Broader conditions

Chronic Disease (3)  ·  Digestive System Diseases (3)  ·  Disease Attributes (3)  ·  Pancreatic Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Dyslipidemias (1)  ·  Hyperlipidemias (1)  ·  Lipid Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Lactose (1)  ·  Saline Solution (1)  ·  Simvastatin (1)  ·  semaglutide (1)

Sponsors

Enrique de-Madaria (1)  ·  Peking Union Medical College Hospital (1)  ·  University of Cagliari (1)

Countries

China (1)  ·  Italy (1)  ·  Spain (1)

Top investigators

Mauro Podda, MD (1)

Results publications

PMID 33644082, PMID 40033414, PMID 41482454